Contract 75N95026D00001
Sri International · Department Of Health And Human Services · July 2, 2026
Sri International was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 2, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $49.89 million.
Contract details
- PIID
- 75N95026D00001
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- July 2, 2026
Description
"EO 14398"; IDIQ: CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG PRODUCTS (TRND 3)
Modification timeline
-
July 2, 2026Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
| Eminent Services Corp | Department Of Health And Human Services | June 24, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95026D00001?
Contract 75N95026D00001 is a federal contract awarded to Sri International by Department Of Health And Human Services on July 2, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N95026D00001?
Sri International won contract 75N95026D00001 from Department Of Health And Human Services.
How much is contract 75N95026D00001 worth?
Contract 75N95026D00001 has obligated $0 to date but carries a potential ceiling of $49.89 million if fully funded and all options are exercised.